Briones-Urbina R, Parkes A B, Bogner U, Mariotti S, Walfish P G
Mount Sinai Hospital, University of Toronto, Canada.
J Endocrinol Invest. 1990 Dec;13(11):879-86. doi: 10.1007/BF03349646.
To evaluate possible immunological mechanisms involved in the development of postpartum thyroiditis with transient hyperthyroidism followed by transient hypothyroidism (PPT), antithyroid peroxidase antibodies (anti-TPO), antimicrosomal antibody (AMA) related immunoglobin G subclass and antibody-dependent cell-mediated cytotoxicity (ADCC) were studied in 43 post-partum (PP) women who were euthyroid at delivery and completed a subsequent 1 year follow up. Among the 25 mothers who developed PPT, 14 had positive AMA (PPT:AMA+) and 11 negative AMA (PPT:AMA-) at delivery. Among the 18 mothers who remained euthyroid (E) up to one year post-partum and were used as controls, 8 were AMA positive (E:AMA+) and 10 AMA negative (E:AMA-) at delivery. AMA measured by a hemagglutination method correlated well with anti-TPO antibodies measured by RIA in the PP mothers studied. When AMA-related IgG subclass activity was analysed comparing PPT women with appropriate euthyroid controls at the different time intervals studied, it was seen that PPT:AMA+ when compared to E:AMA+ women have significantly increased activity of AMA related IgG1 at all PP time intervals studied (p less than 0.001), but IgG4 was only increased at 5-7 months PP (p less than 0.05). PPT:AMA-when compared to E:AMA- have significantly increased IgG4 at 2-4 (p less than 0.001), 5-7 and 10-12 (p less than 0.05) months PP, but IgG1 is only increased at 5-7 months PP (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
为评估产后甲状腺炎伴短暂性甲状腺功能亢进继而短暂性甲状腺功能减退(PPT)发生过程中可能涉及的免疫机制,我们对43例产后妇女进行了研究,这些妇女在分娩时甲状腺功能正常,并完成了随后1年的随访。在25例发生PPT的母亲中,14例在分娩时抗微粒体抗体(AMA)阳性(PPT:AMA+),11例AMA阴性(PPT:AMA-)。在18例产后1年甲状腺功能仍正常(E)并作为对照的母亲中,8例在分娩时AMA阳性(E:AMA+),10例AMA阴性(E:AMA-)。在所研究的产后母亲中,通过血凝法检测的AMA与通过放射免疫分析法检测的抗甲状腺过氧化物酶抗体相关性良好。在不同时间间隔对PPT妇女与相应甲状腺功能正常的对照进行比较分析AMA相关IgG亚类活性时发现,在所有研究的产后时间间隔内,与E:AMA+妇女相比,PPT:AMA+妇女的AMA相关IgG1活性显著增加(p<0.001),但IgG4仅在产后5 - 7个月增加(p<0.05)。与E:AMA-相比,PPT:AMA-在产后2 - 4个月(p<0.001)、5 - 7个月和10 - 12个月(p<0.05)时IgG4显著增加,但IgG1仅在产后5 - 7个月增加(p<0.05)。(摘要截短至250字)